TA 1 |
The technology must have final approval from the appropriate government regulatory bodies |
Approval via 510(k) process is streamlined for new devices that are similar to older devices |
TA 2 |
The scientific evidence must permit conclusions concerning the effectiveness of the technology regarding health outcomes |
Range: Levels 1–5, e.g., level 1, randomized, controlled trials powered to demonstrate clinically significant outcomes; level 5, case series without controls |
TA 3 |
The technology must improve net health outcomes |
Diagnostic tests must change management in ways that benefit patients |
TA 4 |
The technology must be as beneficial as any established alternatives |
It remains unclear how to evaluate diagnostic/prognostic tests lacking a gold-standard reference |
TA 5 |
The improvement must be attainable outside the investigational setting |
By definition, trials are conducted within an investigational setting, and therefore this criterion implies a speculation about potential, and not actually studied, applications |